About this document

LUAVOSI Handout by ELFinch is a document available to read on EtoBox.

Osimertinib, marketed as LUAVOSI, is a medication used to treat EGFR T790M mutation-positive advanced non-small cell lung cancer by inhibiting tyrosine kinases involved in cancer cell processes. It is taken orally once daily and may cause side effects such as nausea, diarrhea, and potential heart or lung issues, necessitating regular monitoring. Patients should avoid grapefruit, report any severe symptoms, and consult their healthcare team regarding drug interactions and management of side effects.

Author

ELFinch

Language

EN